Effects of High-Intensity Interval Training and Moderate-Intensity Continuous Training on Psychological Distress and Self-Regulation in Insufficiently Active Male University Students
NCT07917169, Not applicable, Completed, Burcu Sıla SEZER
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effects of High-Intensity Interval Training and Moderate-Intensity Continuous Training on Psychological Distress and Self-Regulation in Insufficiently Active Male University Students | ClinicalTrials.gov |
| NCT number | NCT07917169 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 36 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Burcu Sıla SEZER | ClinicalTrials.gov |
| Conditions | Psychological Distress, Self-control, Emotion Regulation, Physical Inactivity | ClinicalTrials.gov |
| Interventions | High-Intensity Interval Training (HIIT), Moderate-Intensity Continuous Training | ClinicalTrials.gov |
| First posted | 2026-11-04 | ClinicalTrials.gov |
| Last updated | 2026-11-04 | ClinicalTrials.gov |
Registered outcomes 3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Psychological Distress Measured by the 12-Item General Health Questionnaire (GHQ-12) | Baseline and 48-72 hours after the final exercise session following the eight-week intervention.Total scores range from 0 to 36, with higher scores indicating greater psychological distress. | Psychological distress was assessed using the 12-item General Health Questionnaire (GHQ-12). Higher total scores indicate greater psychological distress. Changes from baseline to the end of the eight-week intervention were compared across the three groups. | ClinicalTrials.gov |
| Primary | Change in Self-Control Measured by the 9-Item Brief Self-Control Scale (BSCS-9) | Baseline and 48-72 hours after the final exercise session following the eight-week intervention. | Self-control was assessed using the 9-item Brief Self-Control Scale (BSCS-9). Higher scores indicate greater self-control. Changes from baseline to post-intervention were compared across the three groups. | ClinicalTrials.gov |
| Primary | Change in Emotion Regulation Measured by the Emotion Regulation Questionnaire (ERQ) | Baseline and 48-72 hours after the final exercise session following the eight-week intervention. | Emotion regulation was assessed using the Turkish version of the 10-item Emotion Regulation Questionnaire (ERQ). Items are rated on a 7-point Likert scale. The questionnaire assesses cognitive reappraisal (six items) and expressive suppression (four items). Each subscale is scored separately as the mean of its items, ranging from 1 to 7. Higher scores indicate more frequent use of the respective strategy. No overall total score is calculated. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)